Amundi - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 147 filers reported holding ITEOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
Amundi ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,263
-32.3%
1,7990.0%0.00%
Q2 2023$24,035
+0.9%
1,7990.0%0.00%
Q1 2023$23,819
-31.0%
1,7990.0%0.00%
Q4 2022$34,541
-1.3%
1,7990.0%0.00%
Q3 2022$35,0001,7990.00%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$52,174,00019.87%
MPM BioImpact LLC 1,745,943$33,260,0007.88%
Boxer Capital, LLC 2,154,058$41,035,0002.31%
TANG CAPITAL MANAGEMENT LLC 937,500$17,859,0002.19%
RA Capital Management 4,417,259$84,149,0001.80%
BVF INC/IL 1,810,835$34,496,0001.42%
Zebra Capital Management LLC 12,271$234,0000.89%
Integral Health Asset Management, LLC 195,000$3,715,0000.72%
Prairiewood Capital, LLC 32,269$615,0000.51%
DAFNA Capital Management LLC 97,560$1,859,0000.50%
View complete list of ITEOS THERAPEUTICS INC shareholders